Projects per year
- 1 - 50 out of 126 results
Search results
-
Active
-
A Phase 1/2 Study of Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) after Receipt of EUA Vaccines
7/14/21 → 11/30/22
Project: Other project
-
A Phase 3 International, Multicenter, Open-label Study to Evaluate the Safety and Immunogenicity of 9vHPV Vaccine Administered as 2-dose Regimen with Extended Dosing Intervals in 9- to 14-Year Old Boys and Girls Compared with a Standard 3-dose Regimen
Merck Sharp & Dohme Corporation
12/22/20 → 12/21/25
Project: Other project
-
Vaccine and Treatment Evaluation Units (VTEU)- COVID Supplement
7/13/20 → 11/30/22
Project: Other project
-
Vaccine and Treatment Evaluation Units (VTEU)- COVID Supplement
7/13/20 → 11/30/22
Project: Other project
-
A Phase 1, Randomized, Single Dose, Blinded, Dose-Escalation Study to Assess Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active Comparator
Astellas Pharma Global Development Inc
6/19/20 → 6/18/23
Project: Other project
-
Comprehensive Analysis of CMV-specific T cells in Human Subjects Receiving a Replication-defective Human Cytomegalovirus Vaccine
8/28/18 → 8/27/22
Project: Other project
-
Completed
-
-
-
Zmapp Expanded Access Protocol, The University of Texas Medical Branch (UTMB)
6/27/19 → 6/30/21
Project: Other project
-
Zmapp Expanded Access Protocol, The University of Texas Medical Branch (UTMB)
6/27/19 → 6/30/21
Project: Other project
-
Zmapp Expanded Access Protocol, The University of Texas Medical Branch (UTMB)
6/27/19 → 6/30/21
Project: Other project
-
Zmapp Expanded Access Protocol, The University of Texas Medical Branch (UTMB)
6/27/19 → 6/30/21
Project: Other project
-
Comprehensive Analysis of CMV-specific T cells in Human Subjects Receiving a Replication-defective Human Cytomegalovirus Vaccine
8/28/18 → 8/27/21
Project: Other project